During the past decade, Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "AGO Study Group" with 4 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Philipps University Marburg Medical Center" with 1 trials sponsored and "PregLem SA" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe" #1 collaborator was "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Else Kröner-Fresenius-Stiftung (funding)" with 1 trials as a collaborator, "European Breast Cancer Reseach Association of Surgical Trialists" with 1 trials as a collaborator and "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe" are "Breast Cancer" (8 trials), "Fallopian Tube Cancer" (5 trials), "Ovarian Cancer" (5 trials), "Breast Cancer Female" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe" in a lesser frequency.

Most popular intervention types in "Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe" are "Drug" (15 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (3 trials), "Atezolizumab" (2 trials), "Capecitabine" (2 trials), "Carboplatin" (2 trials) and "Letrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe" are 10 trials for "Female" genders and 8 trials for "All" genders.

Currently, there are NaN active trials in "Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".